NetworkNewsBreaks – The Supreme Cannabis Company
Post# of 316
(Total Views: 122)
Posted On: 04/22/2019 4:42:25 PM
NetworkNewsBreaks – The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Launch of Cambium Plant Sciences
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) this morning announced the launch of its Goderich, Ontario-based wholly owned subsidiary, Cambium Plant Sciences, which aims to lead the cannabis genetics agricultural revolution and redefine cultivation economics and consumer experiences across the global cannabis industry. According to the update, Cambium will leverage a systematic application of research, technology and science with a focus on developing the next generation of premium cannabis genetics for recreational, medical and wellness applications.
“Our proprietary genetics selection methodology and ability to cultivate high-end cannabis at scale at 7ACRES has created strong industry demand for our proprietary genetics and cultivation techniques. It was as a result of the demand that we saw a global opportunity to create a company whose sole focus is innovating plant genetics and cultivation IP for the global cannabis market,” Supreme Cannabis CEO Navdeep Dhaliwal said in the news release. “We believe genetics are the foundation of proprietary cannabis products in the long term. Cambium will develop cultivars that benefit our in-house brands, as well as our domestic and global cultivation and manufacturing partners. Initially, Cambium is expected to benefit from 7ACRES’ established genetics, existing infrastructure and the unparalleled plant knowledge of its team.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) this morning announced the launch of its Goderich, Ontario-based wholly owned subsidiary, Cambium Plant Sciences, which aims to lead the cannabis genetics agricultural revolution and redefine cultivation economics and consumer experiences across the global cannabis industry. According to the update, Cambium will leverage a systematic application of research, technology and science with a focus on developing the next generation of premium cannabis genetics for recreational, medical and wellness applications.
“Our proprietary genetics selection methodology and ability to cultivate high-end cannabis at scale at 7ACRES has created strong industry demand for our proprietary genetics and cultivation techniques. It was as a result of the demand that we saw a global opportunity to create a company whose sole focus is innovating plant genetics and cultivation IP for the global cannabis market,” Supreme Cannabis CEO Navdeep Dhaliwal said in the news release. “We believe genetics are the foundation of proprietary cannabis products in the long term. Cambium will develop cultivars that benefit our in-house brands, as well as our domestic and global cultivation and manufacturing partners. Initially, Cambium is expected to benefit from 7ACRES’ established genetics, existing infrastructure and the unparalleled plant knowledge of its team.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Supreme Pharmaceuticals (SPRWF) Stock Research Links
Scroll down for more posts ▼